Bivalirudin versus heparin in patients planned for coronary stenting

(Brigham and Women's Hospital) Researchers from Brigham and Women's Hospital conducted an analysis of all of the previous trials to date to better define both the benefits and risks of the competing anticoagulants. They found that, compared with heparin-based regimens, bivalirudin-based regimens increased the risk of heart attack and stent thrombosis. Bivalirudin-based regimens decreased the risk of bleeding, but by how much depended on whether other blood thinners were used more with heparin than with bivalirudin.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news